Piramal Pharma Ltd.

₹179.95

- 0.60 (-0.33%)

04:01 pm - close price

BSE: PPLPHARMA

NSE: PPLPHARMA

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 0.69Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.69Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 6.61Good: 20

❌

Current Ratio

Bad: 1Current: 1.54Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 1.14Good: 15

❌

Debt to Total Assets

Bad: 1Current: 30.88Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.69Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.69Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 6.61Good: 20

❌

Current Ratio

Bad: 1Current: 1.54Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 1.14Good: 15

❌

Debt to Total Assets

Bad: 1Current: 30.88Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	1748.85	1911.38	1958.57	2552.36	1951.14
Expenditure+	1616.53	1645.74	1690.20	2022.43	1746.65
Other Income+	38.31	49.19	61.51	26.38	19.54
Operating Profit	132.32	265.64	268.37	529.93	204.49
Interest	118.52	109.87	105.88	114.22	106.96
Depreciation and Amortization	173.61	184.51	186.32	196.13	184.55
Profit Before Tax	-107.11	39.56	19.36	227.48	-45.08
Tax+	-8.53	34.54	9.25	126.21	43.56
Net Profit	-98.58	5.02	10.11	101.27	-88.64

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	6314.90	6559.10	7081.55	8171.16	9151.18
Operational Expenses+	4886.94	5609.44	6453.31	7000.65	7733.31
Operating Profit	1427.96	949.66	628.24	1170.51	1417.87
Other Income	164.11	275.80	225.11	201.14	161.77
OPM %	22.61	14.48	8.87	14.32	15.49
Depreciation and Amortisation	545.04	586.18	676.69	740.57	816.34
Interest	163.45	198.25	344.18	448.49	421.59
Profit Before Tax	949.05	484.98	-120.15	179.29	414.64
Tax	114.02	109.02	53.85	166.51	324.42
Net Profit	835.03	375.96	-186.46	17.82	91.13

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	10756.08	12717.19	14436.54	14925.31	15284.46
Liabilities+	10756.08	12717.19	14436.54	14925.31	15284.46

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	597.58	766.42	483.89	1004.54	892.30
Cash from Investing Activity	-4479.93	-1812.10	-1338.78	-434.01	-477.46
Cash from Financing Activity	3976.83	794.19	817.79	-422.36	-440.83
Net Cash Flow	94.48	-251.49	-37.10	148.17	-25.99
Opening Cash & Cash Equivalents	151.95	261.97	85.18	53.23	219.19
Closing Cash & Cash Equivalents	261.97	85.18	53.23	219.19	182.32

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	34.86	34.86	34.95	34.95	34.95	34.95	35.02	35.02	35.02	34.79
Public+	65.14	65.14	65.05	65.05	65.05	65.05	64.98	64.98	64.98	65.21
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	462511	458430	432843	418442	359751	306398	297996	292312	300606	277270

Ratios

Reported EPS

Bad: 2Current: 0.69Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.69Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 6.61Good: 20

❌

Current Ratio

Bad: 1Current: 1.54Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 1.14Good: 15

❌

Debt to Total Assets

Bad: 1Current: 30.88Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.69Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.69Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 6.61Good: 20

❌

Current Ratio

Bad: 1Current: 1.54Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 1.14Good: 15

❌

Debt to Total Assets

Bad: 1Current: 30.88Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	597.58	766.42	483.89	1004.54	892.30
Cash from Investing Activity	-4479.93	-1812.10	-1338.78	-434.01	-477.46
Cash from Financing Activity	3976.83	794.19	817.79	-422.36	-440.83
Net Cash Flow	94.48	-251.49	-37.10	148.17	-25.99
Opening Cash & Cash Equivalents	151.95	261.97	85.18	53.23	219.19
Closing Cash & Cash Equivalents	261.97	85.18	53.23	219.19	182.32

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	10756.08	12717.19	14436.54	14925.31	15284.46
Liabilities+	10756.08	12717.19	14436.54	14925.31	15284.46

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	1748.85	1911.38	1958.57	2552.36	1951.14
Expenditure+	1616.53	1645.74	1690.20	2022.43	1746.65
Other Income+	38.31	49.19	61.51	26.38	19.54
Operating Profit	132.32	265.64	268.37	529.93	204.49
Interest	118.52	109.87	105.88	114.22	106.96
Depreciation and Amortization	173.61	184.51	186.32	196.13	184.55
Profit Before Tax	-107.11	39.56	19.36	227.48	-45.08
Tax+	-8.53	34.54	9.25	126.21	43.56
Net Profit	-98.58	5.02	10.11	101.27	-88.64

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	6314.90	6559.10	7081.55	8171.16	9151.18
Operational Expenses+	4886.94	5609.44	6453.31	7000.65	7733.31
Operating Profit	1427.96	949.66	628.24	1170.51	1417.87
Other Income	164.11	275.80	225.11	201.14	161.77
OPM %	22.61	14.48	8.87	14.32	15.49
Depreciation and Amortisation	545.04	586.18	676.69	740.57	816.34
Interest	163.45	198.25	344.18	448.49	421.59
Profit Before Tax	949.05	484.98	-120.15	179.29	414.64
Tax	114.02	109.02	53.85	166.51	324.42
Net Profit	835.03	375.96	-186.46	17.82	91.13

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	34.86	34.86	34.95	34.95	34.95	34.95	35.02	35.02	35.02	34.79
Public+	65.14	65.14	65.05	65.05	65.05	65.05	64.98	64.98	64.98	65.21
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	462511	458430	432843	418442	359751	306398	297996	292312	300606	277270

Piramal Pharma Ltd.

₹179.95

- 0.60 (-0.33%)

04:01 pm - close price

BSE: PPLPHARMA

NSE: PPLPHARMA

Industry: Pharmaceuticals & Drugs

House: Private

Overview